UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars

Targeted oncology, 2017-10, Vol.12 (5), p.599-610

2017

Volltextzugriff (PDF)

Comparison of the pharmacokinetics and pharmacodynamics of S‐1 between Caucasian and East Asian patients

Cancer science, 2011-02, Vol.102 (2), p.478-483

2011

Volltextzugriff (PDF)

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4708-4713

2008

Volltextzugriff (PDF)

Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors

Journal of clinical oncology, 2009-07, Vol.27 (21), p.3557-3565

2009

Volltextzugriff (PDF)

Phase 1 dose‐escalation trial evaluating the combination of the selective MET (mesenchymal‐epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib

Cancer, 2012-12, Vol.118 (23), p.5903-5911

2012

Volltextzugriff (PDF)

VEGF‐Targeted Therapy: Therapeutic Potential and Recent Advances

The oncologist (Dayton, Ohio), 2005-06, Vol.10 (6), p.382-391

Rosen, Lee S.

2005

Volltextzugriff (PDF)

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

Clinical cancer research, 2009-06, Vol.15 (12), p.4213-4219

2009

Volltextzugriff (PDF)

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3150-3157

2003

Volltextzugriff (PDF)

Safety, Pharmacokinetics, and Efficacy of AMG 706, an Oral Multikinase Inhibitor, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2007-06, Vol.25 (17), p.2369-2376

2007

Volltextzugriff (PDF)

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

The New England journal of medicine, 2000-09, Vol.343 (13), p.905-914

2000

Volltextzugriff (PDF)

Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review

The oncologist (Dayton, Ohio), 2010-03, Vol.15 (3), p.216-235

2010

Volltextzugriff (PDF)

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

Thyroid (New York, N.Y.), 2007-04, Vol.17 (4), p.351-355

2007

Volltextzugriff (PDF)

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels

Science advances, 2021-10, Vol.7 (41), p.eabi7511-eabi7511

2021

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for metastatic colon cancer : A cautionary note

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9073-9078

2005

Volltextzugriff (PDF)

Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4793-4799

2007

Volltextzugriff (PDF)

Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5194-5200

2006

Volltextzugriff (PDF)

Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors

Journal of clinical oncology, 2015-03, Vol.33 (9), p.1060-1066

2015

Volltextzugriff (PDF)

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.357-371

2010

Volltextzugriff (PDF)

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1452-1458

2003

Volltextzugriff (PDF)

First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies

Clinical cancer research, 2020-03, Vol.26 (5), p.1025-1033

2020

Volltextzugriff (PDF)

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours

British journal of cancer, 2018-01, Vol.118 (2), p.153-161

2018

Volltextzugriff (PDF)

A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

Clinical cancer research, 2012-09, Vol.18 (17), p.4820-4829

2012

Volltextzugriff (PDF)

A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer

Clinical cancer research, 2017-04, Vol.23 (8), p.1910-1919

2017

Volltextzugriff (PDF)

Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib

Cancer, 2015-05, Vol.121 (9), p.1405-1413

2015

Volltextzugriff (PDF)

1 – 25 von 1.676

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.429)
Mit Volltextzugriff
(1.393)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars

Comparison of the pharmacokinetics and pharmacodynamics of S‐1 between Caucasian and East Asian patients

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors

Phase 1 dose‐escalation trial evaluating the combination of the selective MET (mesenchymal‐epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib

VEGF‐Targeted Therapy: Therapeutic Potential and Recent Advances

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Safety, Pharmacokinetics, and Efficacy of AMG 706, an Oral Multikinase Inhibitor, in Patients With Advanced Solid Tumors

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels

Neoadjuvant chemotherapy for metastatic colon cancer : A cautionary note

Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy

Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors

Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours

A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer

Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib

Suchergebnisse filtern